Brazil keeps waging the good fight on AIDS
■"Brazil and Abbott Reach Price Deal On AIDS Drug," by Reuters, Wall Street Journal, 12 October 2005, p. B3.
Brazil works a deal with Abbott Labs "that almost halves the price it pays for an important AIDS drug, meaning it won't follow through on its threat to break the U.S. company's patent."
Good move by Abbott. Tough but defensible stance by Brazil, which becomes a key champion of the Gap and its pressing healthcare needs.